CA
ABBV icon

Corrado Advisors’s AbbVie ABBV Stock Holding History

Corrado Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,794
Closed -$267K – 80
2023
Q3 		$267K Buy
+1,794
New +$263K 0.18% 100
2023
Q2 		– Sell
-1,708
Closed -$272K – 88
2023
Q1 		$272K Sell
1,708
-309
-15% -$47.2K 0.18% 103
2022
Q4 		$326K Buy
+2,017
New +$309K 0.23% 94

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Corrado Advisors's ABBV Position: Q4 2023 in Review

Corrado Advisors sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 1,794 shares — an estimated $267K sold.

Corrado Advisors first reported a position in ABBV in Q4 2022 and held it in 3 quarters. The position peaked at $326K in Q4 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Corrado Advisors reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • Corrado Advisors sold 1,794 AbbVie shares in Q4 2023, an estimated $267K.
  • Corrado Advisors first reported a position in AbbVie in Q4 2022 and held it in 3 quarters.
  • Corrado Advisors's AbbVie position peaked at $326K in Q4 2022.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Corrado Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.